GC0000096A - Treatment of female sexual dysfunction. - Google Patents

Treatment of female sexual dysfunction.

Info

Publication number: GC0000096A
Authority: GC; Cooperation Council for the Arab states of the Gulf
Prior art keywords: treatment; sexual dysfunction; female sexual; female; dysfunction
Prior art date: 1998-01-30

Application number

Other languages

English (en)

Inventor

Ragab Al-Rashidy

Bruce Ronsen

Original Assignee

Pentech Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-30

Filing date

1999-01-31

Publication date

2005-06-29

1999-01-31 Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc

2005-06-29 Application granted granted Critical

2005-06-29 Publication of GC0000096A publication Critical patent/GC0000096A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

GCP199973 1998-01-30 1999-01-31 Treatment of female sexual dysfunction. GC0000096A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/016,252 US5945117A (en)	1998-01-30	1998-01-30	Treatment of female sexual dysfunction

Publications (1)

Publication Number	Publication Date
GC0000096A true GC0000096A (en)	2005-06-29

Family

ID=21776169

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GCP199973 GC0000096A (en)	1998-01-30	1999-01-31	Treatment of female sexual dysfunction.

Country Status (34)

Country	Link
US (2)	US5945117A (es)
EP (1)	EP1056419A4 (es)
JP (1)	JP2002501875A (es)
KR (1)	KR20010040477A (es)
CN (1)	CN1250221C (es)
AR (1)	AR017976A1 (es)
AU (1)	AU752928B2 (es)
BG (1)	BG64667B1 (es)
BR (1)	BR9908038A (es)
CA (1)	CA2322289A1 (es)
CO (1)	CO4970819A1 (es)
CR (1)	CR5959A (es)
DZ (1)	DZ2714A1 (es)
GC (1)	GC0000096A (es)
GT (1)	GT199900013A (es)
HK (1)	HK1040901B (es)
HN (1)	HN1999000015A (es)
HU (1)	HUP0101268A3 (es)
IL (2)	IL137569A0 (es)
JO (1)	JO2085B1 (es)
MA (1)	MA26600A1 (es)
MX (1)	MXPA00007447A (es)
NO (1)	NO319821B1 (es)
NZ (1)	NZ506597A (es)
PA (1)	PA8467801A1 (es)
PE (1)	PE20000240A1 (es)
PL (1)	PL194350B1 (es)
SK (1)	SK11362000A3 (es)
TN (1)	TNSN99008A1 (es)
TR (1)	TR200002220T2 (es)
TW (1)	TW550069B (es)
UY (1)	UY25374A1 (es)
WO (1)	WO1999038467A1 (es)
ZA (1)	ZA99686B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6395744B1 (en) *	1994-04-22	2002-05-28	Queen's University At Kingston	Method and compositions for the treatment or amelioration of female sexual dysfunction
US20020165122A1 (en) *	1994-04-22	2002-11-07	Heaton Jeremy P. W.	Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) *	1996-02-02	2005-03-24	Nitromed, Inc.	Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en)	1997-10-31	2002-10-29	Nitromed, Inc.	Methods for treating female sexual dysfunctions
US5945117A (en) *	1998-01-30	1999-08-31	Pentech Pharmaceuticals, Inc.	Treatment of female sexual dysfunction
AU2003204720B2 (en) *	1998-05-29	2006-06-29	Tap Pharmaceutical Products Inc.	Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
WO1999066909A2 (en) *	1998-06-22	1999-12-29	Univ Kingston	Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050245494A1 (en) *	1999-07-01	2005-11-03	40 J's Llc	Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20040254153A1 (en) *	1999-11-08	2004-12-16	Pfizer Inc	Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) *	2000-03-20	2001-10-16	Abbott Lab	Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
MXPA02009904A (es) *	2000-04-07	2004-09-06	Tap Pharmaceutical Prod Inc	Derivados de apomorfina y metodos para su uso.
DE60131644T2 (de) *	2000-05-09	2008-10-30	Nitromed, Inc., Lexington	Infrarotthermographie und behandlung von sexuellen dysfunktionen
US6737084B2 (en)	2000-06-27	2004-05-18	Qualilife	Compositions and methods for enhancing or treating female sexual response
US7223406B2 (en)	2000-07-21	2007-05-29	The Regents Of The University Of California	Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
EP1365794A2 (en) *	2000-07-21	2003-12-03	Lue, Tom	Prevention and treatment of sexual arousal disorders
US20020065286A1 (en) *	2000-08-21	2002-05-30	Davies Michael John	Treatment of wounds
PL361875A1 (en)	2000-11-15	2004-10-04	Tap Pharmaceutical Products, Inc.	Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
PL365890A1 (en) *	2000-11-22	2005-01-10	Abbott Laboratories	The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
EP1365740A1 (en) *	2001-02-08	2003-12-03	Pharmacia Corporation	Rapid-onset medicament for the treatment of sexual dysfunction
CA2479372A1 (en) *	2002-03-19	2003-10-02	Michael Holick	Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US20030219696A1 (en) *	2002-05-23	2003-11-27	Moreland Gerald W.	Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en)	2002-08-28	2002-10-02	Pfizer Ltd	Oxytocin inhibitors
GB0221711D0 (en) *	2002-09-19	2002-10-30	Ardana Bioscience Ltd	Methods
US20040138291A1 (en) *	2002-10-10	2004-07-15	Adams Michael A.	Treatment of sexual dysfunction
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
US20040204439A1 (en) *	2003-04-14	2004-10-14	Staniforth John Nicholas	Composition, device, and method for treating sexual dysfunction via inhalation
CA2522231A1 (en) *	2003-04-14	2004-10-21	Vectura Ltd	Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US7306812B2 (en)	2003-05-09	2007-12-11	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) *	2003-05-09	2007-10-02	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) *	2003-06-17	2003-07-23	Pfizer Ltd	Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) *	2003-08-08	2005-03-10	Pfizer Inc	Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) *	2003-08-20	2005-03-24	Lts Lohmann Therapie-Systeme Ag	Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) *	2003-09-22	2007-11-06	Pfizer Inc.	Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) *	2004-04-30	2004-06-09	Pfizer Ltd	Novel compounds
JP4185154B2 (ja) *	2004-04-30	2008-11-26	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	中枢神経系障害治療用の置換モルホリン化合物
US20080214622A1 (en) *	2005-03-21	2008-09-04	Alan Daniel Brown	Substituted Triazole Derivatives As Oxytocin Antagonists
EP1863795B1 (en) *	2005-03-21	2008-10-29	Pfizer Limited	Substituted triazole derivatives as oxytocin antagonists
RU2406480C2 (ru) *	2005-04-08	2010-12-20	Озфарма Пти Лтд	Трансбуккальная система доставки
JP2009504628A (ja) *	2005-08-10	2009-02-05	ファイザー・リミテッド	オキシトシン拮抗薬としての置換トリアゾール誘導体
EP2010505B1 (en) *	2006-03-28	2012-12-05	Atir Holding S.A.	Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US7800094B2 (en) *	2007-06-11	2010-09-21	Macronix International Co., Ltd.	Resistance memory with tungsten compound and manufacturing
ES2699077T3 (es)	2009-06-12	2019-02-07	Sunovion Pharmaceuticals Inc	Apomorfina sublingual
WO2011130608A1 (en) *	2010-04-15	2011-10-20	Life Science Enhancement Corporation	Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
PT2651357T (pt)	2010-12-16	2020-06-17	Sunovion Pharmaceuticals Inc	Películas sublinguais
EP2697206B1 (en)	2011-04-10	2019-04-03	Atir Holding S.A.	Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en)	2011-07-11	2013-01-16	Britannia Pharmaceuticals Limited	A new therapeutical composition containing apomorphine as active ingredient
EP4578461A3 (en)	2015-04-21	2025-09-03	Sumitomo Pharma America, Inc.	Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4521421A (en) *	1983-09-26	1985-06-04	Eli Lilly And Company	Treatment of sexual dysfunction
EP0641202A1 (en) *	1992-05-18	1995-03-08	Smithkline Beecham Plc	Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
US5565466A (en) *	1993-08-13	1996-10-15	Zonagen, Inc.	Methods for modulating the human sexual response
WO1995028930A1 (en) *	1994-04-22	1995-11-02	Pentech Pharmaceuticals, Inc.	Dosage forms and method for ameliorating male erectile dysfunction
US5562917A (en) *	1994-12-23	1996-10-08	Pentech Pharmaceuticals, Inc.	Transdermal administration of apomorphine
US5624677A (en) *	1995-06-13	1997-04-29	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) *	1998-01-30	1999-08-31	Pentech Pharmaceuticals, Inc.	Treatment of female sexual dysfunction

1998
- 1998-01-30 US US09/016,252 patent/US5945117A/en not_active Expired - Fee Related
1999
- 1999-01-21 TN TNTNSN99008A patent/TNSN99008A1/fr unknown
- 1999-01-28 CN CNB998044423A patent/CN1250221C/zh not_active Expired - Fee Related
- 1999-01-28 SK SK1136-2000A patent/SK11362000A3/sk unknown
- 1999-01-28 BR BR9908038-9A patent/BR9908038A/pt not_active Application Discontinuation
- 1999-01-28 KR KR1020007008333A patent/KR20010040477A/ko not_active Ceased
- 1999-01-28 HK HK02101988.0A patent/HK1040901B/zh not_active IP Right Cessation
- 1999-01-28 IL IL13756999A patent/IL137569A0/xx active IP Right Grant
- 1999-01-28 CA CA002322289A patent/CA2322289A1/en not_active Abandoned
- 1999-01-28 PL PL99342062A patent/PL194350B1/pl unknown
- 1999-01-28 AU AU25644/99A patent/AU752928B2/en not_active Ceased
- 1999-01-28 JP JP2000529203A patent/JP2002501875A/ja not_active Withdrawn
- 1999-01-28 HN HN1999000015A patent/HN1999000015A/es unknown
- 1999-01-28 TR TR2000/02220T patent/TR200002220T2/xx unknown
- 1999-01-28 NZ NZ506597A patent/NZ506597A/en unknown
- 1999-01-28 HU HU0101268A patent/HUP0101268A3/hu unknown
- 1999-01-28 ZA ZA9900686A patent/ZA99686B/xx unknown
- 1999-01-28 EP EP99905497A patent/EP1056419A4/en not_active Withdrawn
- 1999-01-28 CR CR5959A patent/CR5959A/es not_active Application Discontinuation
- 1999-01-28 MX MXPA00007447A patent/MXPA00007447A/es not_active IP Right Cessation
- 1999-01-28 JO JO19992085A patent/JO2085B1/en active
- 1999-01-28 WO PCT/US1999/001776 patent/WO1999038467A1/en not_active Ceased
- 1999-01-29 PA PA19998467801A patent/PA8467801A1/es unknown
- 1999-01-29 CO CO99005067A patent/CO4970819A1/es unknown
- 1999-01-29 UY UY25374A patent/UY25374A1/es not_active Application Discontinuation
- 1999-01-29 MA MA25442A patent/MA26600A1/fr unknown
- 1999-01-29 TW TW088101384A patent/TW550069B/zh not_active IP Right Cessation
- 1999-01-29 AR ARP990100389A patent/AR017976A1/es not_active Application Discontinuation
- 1999-01-29 PE PE1999000067A patent/PE20000240A1/es not_active Application Discontinuation
- 1999-01-30 DZ DZ990015A patent/DZ2714A1/xx active
- 1999-01-31 GC GCP199973 patent/GC0000096A/xx active
- 1999-07-02 US US09/345,009 patent/US6193992B1/en not_active Expired - Fee Related
2000
- 2000-07-27 IL IL137569A patent/IL137569A/en unknown
- 2000-07-27 NO NO20003845A patent/NO319821B1/no unknown
- 2000-08-28 BG BG104715A patent/BG64667B1/bg unknown
2001
- 2001-07-20 GT GT199900013A patent/GT199900013A/es unknown

Also Published As

Publication number	Publication date
NO20003845L (no)	2000-09-28
KR20010040477A (ko)	2001-05-15
NO319821B1 (no)	2005-09-19
TNSN99008A1 (fr)	2005-11-10
PA8467801A1 (es)	2000-09-29
GT199900013A (es)	2001-07-20
TW550069B (en)	2003-09-01
DZ2714A1 (fr)	2003-09-01
UY25374A1 (es)	1999-09-27
IL137569A (en)	2006-08-01
HUP0101268A3 (en)	2002-12-28
IL137569A0 (en)	2001-07-24
EP1056419A4 (en)	2007-05-02
MA26600A1 (fr)	2004-12-20
PL342062A1 (en)	2001-05-21
NZ506597A (en)	2003-07-25
TR200002220T2 (tr)	2000-12-21
CR5959A (es)	1999-07-28
BR9908038A (pt)	2002-01-02
SK11362000A3 (sk)	2001-02-12
AR017976A1 (es)	2001-10-24
ZA99686B (en)	1999-07-28
JO2085B1 (en)	2000-05-21
HN1999000015A (es)	1999-08-23
US5945117A (en)	1999-08-31
WO1999038467A1 (en)	1999-08-05
AU2564499A (en)	1999-08-16
CN1250221C (zh)	2006-04-12
HK1040901B (zh)	2006-11-24
BG104715A (bg)	2001-02-28
PL194350B1 (pl)	2007-05-31
NO20003845D0 (no)	2000-07-27
EP1056419A1 (en)	2000-12-06
AU752928B2 (en)	2002-10-03
HUP0101268A2 (hu)	2001-09-28
BG64667B1 (bg)	2005-11-30
CA2322289A1 (en)	1999-08-05
CN1313742A (zh)	2001-09-19
PE20000240A1 (es)	2000-03-31
HK1040901A1 (en)	2002-06-28
MXPA00007447A (es)	2006-01-25
JP2002501875A (ja)	2002-01-22
CO4970819A1 (es)	2000-11-07
US6193992B1 (en)	2001-02-27

Publication	Publication Date	Title
GC0000096A (en)	2005-06-29	Treatment of female sexual dysfunction.
EP1027057A4 (en)	2003-01-02	TREATMENT OF FEMALE SEXUAL DISORDERS
IL153492A0 (en)	2003-07-06	Treatment of male sexual dysfunction
IL141553A0 (en)	2002-03-10	Drug preparations for treating sexual dysfunction
GB9608408D0 (en)	1996-06-26	Treatment of erectile dysfunction
GB0225908D0 (en)	2002-12-11	Treatment of female sexual dysfunction
AU3894600A (en)	2000-10-09	Method of treating sexual dysfunction
AU3776799A (en)	1999-11-23	Methods for treating female sexual dysfunction
IL155775A0 (en)	2003-12-23	Treatment of male sexual dysfunction
EP1079764A4 (en)	2001-09-12	TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS
AU5509099A (en)	2000-02-28	Pyridinones for the treatment of sexual dysfunction
AU7652400A (en)	2001-04-17	Novel combination for the treatment of sexual dysfunction
PL362980A1 (en)	2004-11-02	Treatment of sexual dysfunction
GB0204919D0 (en)	2002-04-17	Treatment of female sexual dysfunction
ZA200007396B (en)	2002-02-27	Method of treatment.
ZA200006376B (en)	2002-05-06	Compounds for the treatment of female sexual dysfunction.
GB0030647D0 (en)	2001-01-31	Treatment of male sexual dysfunction
SI1047428T1 (sl)	2007-10-31	Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB0011926D0 (en)	2000-07-05	Treatment of sexual dysfunction
ZA994585B (en)	2001-01-15	Treatment of water.
GB9928178D0 (en)	2000-01-26	Agent for the treatment of male and female sexual dysfunction
GB0108730D0 (en)	2001-05-30	Treatment of male sexual dysfunction
GB0106167D0 (en)	2001-05-02	Treatment of male sexual dysfunction
GB0108483D0 (en)	2001-05-23	Treatment of male sexual dysfunction
GB0120679D0 (en)	2001-10-17	Treatment of male sexual dysfunction